Dolby Laboratories (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock in a transaction that occurred on Monday, August 14th. The stock was sold at an average price of $50.19, for a total value of $5,019,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Wednesday, August 9th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $51.20, for a total value of $2,560,000.00.
  • On Thursday, August 10th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $50.84, for a total value of $5,084,000.00.
  • On Monday, August 7th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $51.26, for a total value of $2,563,000.00.
  • On Tuesday, August 8th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $51.13, for a total value of $5,113,000.00.
  • On Friday, August 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $51.13, for a total value of $5,113,000.00.
  • On Wednesday, August 2nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $52.03, for a total value of $5,203,000.00.
  • On Monday, July 31st, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $52.22, for a total value of $5,222,000.00.

Shares of Dolby Laboratories (DLB) traded down 1.31% during trading on Tuesday, reaching $49.65. The company had a trading volume of 245,972 shares. Dolby Laboratories has a 12 month low of $44.99 and a 12 month high of $55.02. The firm has a market capitalization of $5.09 billion, a P/E ratio of 25.40 and a beta of 0.79. The firm’s 50 day moving average price is $51.29 and its 200 day moving average price is $50.76.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Tuesday, July 25th. The electronics maker reported $0.75 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.10. The firm had revenue of $305.67 million for the quarter, compared to analysts’ expectations of $296.88 million. Dolby Laboratories had a return on equity of 10.25% and a net margin of 19.02%. Dolby Laboratories’s quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.62 EPS. Equities analysts predict that Dolby Laboratories will post $1.99 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Monday, August 7th will be issued a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Thursday, August 3rd. Dolby Laboratories’s dividend payout ratio (DPR) is presently 28.57%.

TRADEMARK VIOLATION NOTICE: “Dagmar Dolby Sells 100,000 Shares of Dolby Laboratories (DLB) Stock” was published by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.americanbankingnews.com/2017/08/15/dagmar-dolby-sells-100000-shares-of-dolby-laboratories-dlb-stock.html.

A number of brokerages recently commented on DLB. B. Riley reiterated a “neutral” rating and set a $57.00 price objective (up previously from $52.00) on shares of Dolby Laboratories in a research report on Tuesday, April 25th. Zacks Investment Research upgraded Dolby Laboratories from a “hold” rating to a “buy” rating and set a $59.00 price objective on the stock in a research report on Friday, April 28th. Finally, BidaskClub downgraded Dolby Laboratories from a “hold” rating to a “sell” rating in a research report on Saturday, June 10th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. Dolby Laboratories has a consensus rating of “Hold” and an average target price of $54.38.

A number of large investors have recently made changes to their positions in DLB. Watermark Asset Management Inc. bought a new stake in shares of Dolby Laboratories during the first quarter worth approximately $114,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Dolby Laboratories by 9.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,331 shares of the electronics maker’s stock worth $114,000 after buying an additional 209 shares during the period. James Investment Research Inc. bought a new stake in shares of Dolby Laboratories during the first quarter worth approximately $155,000. US Bancorp DE boosted its stake in shares of Dolby Laboratories by 4.8% in the first quarter. US Bancorp DE now owns 2,951 shares of the electronics maker’s stock worth $155,000 after buying an additional 135 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its stake in shares of Dolby Laboratories by 25.5% in the second quarter. The Manufacturers Life Insurance Company now owns 3,564 shares of the electronics maker’s stock worth $174,000 after buying an additional 725 shares during the period. Hedge funds and other institutional investors own 50.38% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.